Understand the source comparison
SLU PP332 Same as SS-LUP-332 vs DNP: Critical Safety Distinctions
SLU PP332 same as SS-LUP-332 is frequently compared to 2,4-dinitrophenol (DNP), the industrial chemical infamous for causing fatal hyperthermia when misused as a weight-loss agent. Both are mitochondrial uncouplers, but their safety profiles differ dramaticall
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- SLU PP332 same as SS-LUP-332 is frequently compared to 2,4-dinitrophenol (DNP), the industrial chemical infamous for causing fatal hyperthermia when misused as a weight-loss agent. Both are mitochondrial uncouplers, but their safety profiles differ dramatically. DNP has an extraordinarily narrow therapeutic window. The difference between an effective dose and a lethal dose is less than 2×. Once ingested, DNP cannot be removed or neutralised; its 36-hour half-life means overdose symptoms (uncontrollable hyperthermia, tachycardia, metabolic acidosis) persist until the compound clears naturally, often resulting in death before medical intervention can stabilise core temperature.
- SLU PP332 was specifically designed to avoid DNP's lethality by incorporating pH-dependent protonation that limits uncoupling activity at physiological pH. The compound's structure includes ionisable groups that bind protons more selectively than DNP, reducing uncoupling capacity as intracellular pH drops. Creating a self-limiting feedback mechanism absent in DNP. Rodent LD50 studies published in the original Saint Louis University research showed a therapeutic index (ratio of lethal dose to effective dose) approximately 15× wider than DNP, though still far narrower than conventional pharmaceuticals.
- We've observed researchers mistakenly treating SLU PP332 same as SS-LUP-332 as 'safe DNP'. It's not. It remains an experimental compound with incomplete toxicology profiles, no human clinical trials, and significant hyperthermia risk at doses exceeding recommended ranges. The pH-sensitive design reduces lethality compared to DNP but does not eliminate it. Any research protocol involving this peptide requires continuous core temperature monitoring and immediate cessation if body temperature rises above baseline by more than 1.5°C.